Skip to main content

Recent Articles

Technology, Perspectives
Infant With Rare Condition Becomes First to Successfully Receive Treatment With Personalized Gene Therapy
Read More
FDA Approvals, Pain
FDA Approves First-in-Class Option for Acute Pain
Read More
FDA Approvals, Mental Health
FDA OKs Subcutaneous Apomorphine Infusion for Parkinson’s Treatment
Read More
In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile, Multiple Myeloma, Oncology, Bispecific Antibodies
Ongoing Analyses and Recent Data for Talvey in Multiple Myeloma
Rohan Vashi, PharmD, MSc
Read More
In-Depth Treatment Profile
Imdelltra Approved for Treatment of Extensive-Stage Small Cell Lung Cancer on or Following Disease Progression While on Platinum-Based Chemotherapies
Rohan Vashi, PharmD, MSc
Read More

Recent FDA Approvals

Infectious Diseases, FDA Approvals
Chikungunya Vaccine Fetches FDA Nod for Persons Aged ≥12 Years
Read More
FDA Approvals, Mental Health
FDA OKs Subcutaneous Apomorphine Infusion for Parkinson’s Treatment
Read More
FDA Approvals, Pain
FDA Approves First-in-Class Option for Acute Pain
Read More
FDA Approvals, Neurology
AXS-07 Gets Nod for Acute Migraine Treatment
Read More
Biosimilars, Cardiometabolic Health, FDA Approvals
FDA OKs Rapid-Acting Insulin Biosimilar Product
Read More
In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy
Read More
View the Latest Issue